The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Outbreak of Adverse Reactions Associated with Contaminated Heparin
Open accessAbstract
BACKGROUND: In January 2008, the Centers for Disease Control and Prevention began a nationwide investigation of severe adverse reactions that were first detected in a single hemodialysis facility. Preliminary findings suggested that heparin was a possible cause of the reactions. METHODS: Information on clinical manifestations and on exposure was collected for patients who had signs and symptoms that were consistent with an allergic-type reaction after November 1, 2007. Twenty-one dialysis facilities that reported reactions and 23 facilities that reported no reactions were included in a case-control study to identify facility-level risk factors. Unopened heparin vials from facilities that reported reactions were tested for contaminants. RESULTS: A total of 152 adverse reactions associated with heparin were identified in 113 patients from 13 states from November 19, 2007, through January 31, 2008. The use of heparin manufactured by Baxter Healthcare was the factor most strongly associated with reactions (present in 100.0% of case facilities vs. 4.3% of control facilities, P<0.001). Vials of heparin manufactured by Baxter from facilities that reported reactions contained a contaminant identified as oversulfated chondroitin sulfate (OSCS). Adverse reactions to the OSCS-contaminated heparin were often characterized by hypotension, nausea, and shortness of breath occurring within 30 minutes after administration. Of 130 reactions for which information on the heparin lot was available, 128 (98.5%) occurred in a facility that had OSCS-contaminated heparin on the premises. Of 54 reactions for which the lot number of administered heparin was known, 52 (96.3%) occurred after the administration of OSCS-contaminated heparin. CONCLUSIONS: Heparin contaminated with OSCS was epidemiologically linked to adverse reactions in this nationwide outbreak. The reported clinical features of many of the cases further support the conclusion that contamination of heparin with OSCS was the cause of the outbreak.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events
Guerrini, M., Beccati, D., Shriver, Z., Naggi, A., Viswanathan, K., Bisio, A., Capila, I., Lansing, J. C., Guglieri, S., Fraser, B., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1407 · Cited by 628
Self-citationContaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System
Kishimoto, T. K., Viswanathan, K., Ganguly, T., Elankumaran, S., Smith, S., Pelzer, K., Lansing, J. C., Sriranganathan, N., Zhao, G., Galcheva-Gargova, Z., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803200 · Cited by 621
Self-citationHypersensitivity reactions to anticoagulant drugs: diagnosis and management options
Bircher, A. J., Harr, T., Hohenstein, L., & Tsakiris, D. A. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01227.x · Cited by 147
Hospital-acquired infections related to contaminated substances
Vonberg, R., & Gastmeier, P. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.09.018 · Cited by 132
Haemodialysis‐associated anaphylactic and anaphylactoid reactions
Ebo, D. G., Bosmans, J., Couttenye, M. M., & Stevens, W. J. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.00982.x · Cited by 105
Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors
Pegues, D. A., Beck‐Sagué, C. M., Woollen, S. W., Greenspan, B., Burns, S. M., Bland, L. A., Arduino, M. J., Favero, M. S., Mackow, R. C., & Jarvis, W. R. (1992) · Kidney International · doi:10.1038/ki.1992.409 · Cited by 72
Self-citationHeparin‐induced recurrent anaphylaxis
Berkun, Y., Haviv, Y., Schwartz, L. B., & Shalit, M. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.02129.x · Cited by 62
Wan, S., LeClerc, J.-L., Antoine, M., DeSmet, J.-M., Yim, A. P. C., & Vincent, J. (1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)00701-8 · Cited by 42
Bottio, T., Pittarello, G., Bonato, R., Fagiolo, U., & Gerosa, G. (2003) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(03)00813-4 · Cited by 33
Cited by
World Allergy Organization Anaphylaxis Guidance 2020
Cardona, V., Ansotegui, I. J., Ebisawa, M., El-Gamal, Y., Fernandez Rivas, M., Fineman, S., Geller, M., Gonzalez-Estrada, A., Greenberger, P. A., Sanchez Borges, M., et al. (2020) · World Allergy Organization Journal · doi:10.1016/j.waojou.2020.100472 · Cited by 1,186
Garcia, D. A., Baglin, T. P., Weitz, J. I., & Samama, M. M. (2012) · Chest · doi:10.1378/chest.11-2291 · Cited by 1,091
ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002706 · Cited by 515
Pharmacology of Heparin and Related Drugs
Mulloy, B., Hogwood, J., Gray, E., Lever, R., & Page, C. P. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011247 · Cited by 341
Substandard drugs: a potential crisis for public health
Johnston, A., & Holt, D. W. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12298 · Cited by 270
Vitte, J., Sabato, V., Tacquard, C., Garvey, L. H., Michel, M., Mertes, P.-M., Ebo, D. G., Schwartz, L. B., & Castells, M. C. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.03.011 · Cited by 79
Bias in recruitment to cluster randomized trials: a review of recent publications
Brierley, G., Brabyn, S., Torgerson, D., & Watson, J. (2012) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2011.01700.x · Cited by 62
Anaphylaxis: Mediators, Biomarkers, and Microenvironments
Fernandez-Bravo, S., Palacio-Garcia, L., Requena-Robledo, N., Yuste-Montalvo, A., Nuñez-Borque, E., & Esteban, V (2022) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0854 · Cited by 17
Metadata
- Authors
- Blossom, D. B., Kallen, A. J., Patel, P. R., Elward, A., Robinson, L., Gao, G., Langer, R., Perkins, K. M., Jaeger, J. L., Kurkjian, K. M., Jones, M., Schillie, S. F., Shehab, N., Ketterer, D., Venkataraman, G., Kishimoto, T. K., Shriver, Z., McMahon, A. W., Austen, K. F., Kozlowski, S., Srinivasan, A., Turabelidze, G., Gould, C. V., Arduino, M. J., & Sasisekharan, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-12-18
- Volume
- 359
- Issue
- 25
- Pages
- 2674-2684
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1978767835
- Cited by
- 282
- References
- 11
- FWCI
- 28.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.